× Metformin improves diabetic kidney disease

× Antiphospholipid syndrome-associated nephropathy; a nephropathy needs classification

× Hyperuricemia; a new look at an old problem

× Herbal medicine and diabetic kidney disease

× Acute kidney injury; the focus of world kidney day in 2013

× Contrast induced nephropathy; recent findings

× World diabetes day 2013: diabetes mellitus and nephrology

× The awareness of chronic kidney disease and aging; the focus of world kidney day in 2014

× Vitamin D therapy in diabetic kidney disease

× Herbal medicines and kidney; friends or foes?

× Kidney protective effects of melatonin

× Diabetic nephropathy; principles of diagnosis and treatment of diabetic kidney disease

× Pathological patterns of mesangioproliferative glomerulonephritis seen at a tertiary care center

× Mechanism of hypertension in diabetic nephropathy

× Prevention of contrast induced nephropathy; a cardiology point of view

× New concepts in diabetic kidney disease

× Efficacy of dietary interventions in end-stage renal disease patients; a systematic review

× Oxford classification of IgA nephropathy and C4d deposition; correlation and its implication

× A study of primary glomerular diseases in adults; clinical, histopathological and immunofluorescence correlations

× C4d in IgA nephropathy: a marker sans boundaries

× Primary glomerular disease in adults: pattern over decades,interpretation across the globe

× Hepatitis B viremia manifesting as polyarteritis nodosa and secondary membranous nephropathy

× A glimpse of diabetic nephropathy

× Correlation between adiponectin level with common variant (rs9939609) of fat mass and obesity-associated gene in obese type 2 diabetic women

× IgG4-related disease; a unifying entity  

× The demise of contrast nephropathy; can this be true? A contrarian view; a representative case report of contrast nephropathy from Mayo Clinic Health System in Northwestern Wisconsin

× Awareness of diabetic nephropathy in patients with type 2 diabetes mellitus: the Indian scenario

× Diagnosis and predictive clinical and para-clinical cutoffs for diabetes complications in Lur and Lak populations of Iran; a ROC curve analysis to design a regional guideline

× Prevalence and characteristics of diabetic kidney disease in type 2 diabetic patients in Abidjan, Côte d’Ivoire

× Hemoglobin A1c levels in maintenance hemodialysis patients in India

× Updated Oxford classification for IgA nephropathy; current status and future prospects 

× Morphologic lesions of membranous nephropathy in association with various demographic and laboratory parameters of patients; a single center study

× The K469E genetic variant in the ICAM1 gene is associated with type 2 diabetes but not with its vascular complications: a meta-analysis

× Supportive treatment for cast nephropathy in patients with multiple myeloma; a pilot study

× Glomerulonephritis associated with SARS-CoV-2 infection

× The efficiency of remote ischemic preconditioning on serum cystatin C-based acute kidney injury in patients undergoing coronary angiography; a randomized controlled trial

× The effects of sevelamer carbonate on blood glucose and inflammatory factors in patients with diabetic kidney disease; a controlled clinical trial

× Evaluation of urinary NGAL level in children with congenital heart disease as a possible early indicator of nephropathy

× Prevalence of nephropathy and proximal tubule disorder in human immunodeficiency virus patients under tenofovir therapy

× Acute oxalate nephropathy associated with herbal remedies

× Targeted-release budesonide in immunoglobulin A nephropathy; a mini-review

× Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy

× Cancer in IgA nephropathy; a letter to the editor on current findings

× The Mayo Clinic consensus report on membranous nephropathy; a promising step toward better treating the disease

× Comparative histological and clinical differences between children and adults in IgA nephropathy